« Previous
Artery Research
Volume 2, Issue 4
, Pages 156-160
, November 2008
Gender and endothelial progenitor cell number in middle-aged adults
References
- Heart disease and stroke statistics – 2006 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2006;113(6):e85–e151
- . Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension. 2005;46(1):7–18
- Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 2003;93(10):980–989
- Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593–600
- Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111(22):2981–2987
- Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353(10):999–1007
- Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1–E7
- . Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95(4):343–353
- Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103(24):2885–2890
- . Gender differences in endothelial tissue-type plasminogen activator release in middle-aged adults. J Am Coll Cardiol. 2005;45(9):1547–1549
- Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation. 2001;103(15):1936–1941
- . Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847
- . The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5(3):213–226
- Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol. 2004;24(8):1442–1447
- EUSTAR statement and recommendations on endothelial precursor cells. Ann Rheum Dis. 2008;
- Human CD34+ AC133+ VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35(7):1109–1118
- The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation. 2006;114(Suppl. 1):I114–I119
- Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation. 2008;117(23):3020–3030
- . Circulating endothelial progenitor cells as novel biological determinants of vascular function and risk. Can J Cardiol. 2004;20(Suppl. B):44B–48B
- Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol. 2008;28(5):997–1004
- . Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk Res. 1985;9(2):191–198
- Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7(4):430–436
- CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114(20):2163–2169
- . Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood. 2005;106(5):1525–1531
- . Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med. 2003;13(5):201–206
- Peripheral blood CD34+ KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke. 2006;37(9):2277–2282
- Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol. 2007;99(1):46–48
PII: S1872-9312(08)00506-1
doi: 10.1016/j.artres.2008.10.001
© 2008 Association for Research into Arterial Structure and Physiology. Published by Elsevier Inc. All rights reserved.
« Previous
Artery Research
Volume 2, Issue 4
, Pages 156-160
, November 2008
